NEA Management Company’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,685,683
| Closed | -$15.5M | – | 53 |
|
|
2023
Q1 | $15.5M | Hold |
3,685,683
| – | – | 1.07% | 24 |
|
|
2022
Q4 | $22.2M | Hold |
3,685,683
| – | – | 1.24% | 21 |
|
|
2022
Q3 | $21.5M | Sell |
3,685,683
-4,361,545
| -54% | -$25.4M | 1.07% | 26 |
|
|
2022
Q2 | $48M | Buy |
8,047,228
+906,778
| +13% | +$5.41M | 2.47% | 10 |
|
|
2022
Q1 | $99.8M | Hold |
7,140,450
| – | – | 2.88% | 8 |
|
|
2021
Q4 | $17.7M | Hold |
7,140,450
| – | – | 0.36% | 34 |
|
|
2021
Q3 | $21.1M | Hold |
7,140,450
| – | – | 0.25% | 35 |
|
|
2021
Q2 | $17.9M | Hold |
7,140,450
| – | – | 0.23% | 44 |
|
|
2021
Q1 | $20.8M | Hold |
7,140,450
| – | – | 0.47% | 39 |
|
|
2020
Q4 | $23M | Hold |
7,140,450
| – | – | 0.61% | 31 |
|
|
2020
Q3 | $15.4M | Hold |
7,140,450
| – | – | 0.65% | 32 |
|
|
2020
Q2 | $8.28M | Hold |
7,140,450
| – | – | 0.33% | 35 |
|
|
2020
Q1 | $6.57M | Buy |
7,140,450
+3,390,450
| +90% | +$3.12M | 0.34% | 36 |
|
|
2019
Q4 | $5.83M | Hold |
3,750,000
| – | – | 0.28% | 38 |
|
|
2019
Q3 | $3.14M | Hold |
3,750,000
| – | – | 0.26% | 38 |
|
|
2019
Q2 | $3.22M | Hold |
3,750,000
| – | – | 0.23% | 36 |
|
|
2019
Q1 | $3.64M | Hold |
3,750,000
| – | – | 0.19% | 39 |
|
|
2018
Q4 | $2.74M | Hold |
3,750,000
| – | – | 0.11% | 39 |
|
|
2018
Q3 | $8.1M | Hold |
3,750,000
| – | – | 0.35% | 35 |
|
|
2018
Q2 | $18.7M | Hold |
3,750,000
| – | – | 0.87% | 23 |
|
|
2018
Q1 | $14.6M | Buy |
+3,750,000
| New | +$14.6M | 0.65% | 25 |
|